Related Experiment Videos
Disseminated intravascular coagulation. Objective laboratory diagnostic criteria and guidelines for management
1Presbyterian Hospital of Dallas, Texas.
Insights
Disseminated Intravascular Coagulation (DIC) diagnosis and management are clarified, detailing hemostasis system interrelationships. Objective criteria for diagnosis, severity, and therapy response are provided to guide clinicians.
Area of Science:
- Hematology
- Pathophysiology
- Clinical Medicine
Background:
- Disseminated Intravascular Coagulation (DIC) presents complex diagnostic and management challenges.
- Understanding the intricate interrelationships within the hemostasis system is crucial for interpreting DIC findings.
- Many organ-specific syndromes share pathophysiology with DIC, complicating differential diagnosis.
Purpose of the Study:
- To present current concepts on the etiology, pathophysiology, diagnosis, and management of fulminant and low-grade DIC.
- To delineate objective clinical and laboratory criteria for accurate DIC diagnosis.
- To provide guidelines for assessing DIC severity and response to therapy.
Main Methods:
- Comprehensive review of current literature on DIC.
- Analysis of pathophysiological interrelationships within the hemostasis system.
- Delineation of objective diagnostic and therapeutic criteria.
Main Results:
- Objective criteria for diagnosing DIC have been established, reducing diagnostic confusion.
- Clear criteria for assessing DIC severity and response to therapy are presented.
- Guidelines for discontinuing therapy when deemed fruitless are provided.
Conclusions:
- A clear understanding of hemostasis pathophysiology is essential for managing DIC.
- Objective criteria improve diagnostic accuracy and therapeutic decision-making in DIC.
- Individualized therapy tailored to DIC characteristics is paramount for patient outcomes.
Abstract:
Current concepts of the etiology, pathophysiology, clinical and laboratory diagnosis, and management of fulminant and low-grade DIC have been presented. Considerable attention has been devoted to interrelationships within the hemostasis system. Only by clearly understanding these pathophysiological interrelationships can the clinician and laboratory scientist appreciate the divergent and wide spectrum of often confusing clinical and laboratory findings in patients with DIC. In this discussion, objective clinical and laboratory criteria for the diagnosis of DIC have been delineated, thus eradicating needless confusion and empirical decisions regarding the diagnosis. Many therapeutic decisions to be made are controversial and will remain so until more is published about specific therapeutic modalities and survival patterns. Also, therapy must be highly individualized depending on the nature of DIC, age, etiology of DIC, site and severity of hemorrhage or thrombosis, and hemodynamic and other clinical parameters. Also presented are clear criteria for the severity of DIC and objective criteria for defining a response to therapy. Because it frequently is difficult for the individual physician to decide when to stop often extensive and expensive therapy, objective criteria whereby therapy may be stopped, as it is deemed that continuation is most likely fruitless, have been presented as a guideline. Many syndromes, which frequently are organ-specific, share common pathophysiology with DIC but are typically identified as an independent disease entity, for example, hemolytic uremic syndrome, adult shock-lung syndrome, eclampsia, and many other isolated organ-specific disorders.